Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson, Brian Halabisky, Jong W. Yoo, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 2, pp. 700-711
Open Access | Times Cited: 611

Showing 1-25 of 611 citing articles:

Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez, et al.
Neurodegenerative Diseases (2012) Vol. 11, Iss. 4, pp. 165-181
Open Access | Times Cited: 10212
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran, Marc Mercken, Bart De Strooper
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 9, pp. 698-712
Closed Access | Times Cited: 2056
Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model
Laure Verret, Edward O. Mann, Giao B. Hang, et al.
Cell (2012) Vol. 149, Iss. 3, pp. 708-721
Open Access | Times Cited: 1067
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Tara L. Spires‐Jones, Bradley T. Hyman
Neuron (2014) Vol. 82, Iss. 4, pp. 756-771
Open Access | Times Cited: 1030
Tau pathology and neurodegeneration
Maria Grazia Spillantini, Michel Goedert
The Lancet Neurology (2013) Vol. 12, Iss. 6, pp. 609-622
Closed Access | Times Cited: 1000
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Lennart Mucke, Dennis J. Selkoe
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 7, pp. a006338-a006338
Open Access | Times Cited: 933
Synergy between amyloid-β and tau in Alzheimer’s disease
Marc Aurel Busche, Bradley T. Hyman
Nature Neuroscience (2020) Vol. 23, Iss. 10, pp. 1183-1193
Closed Access | Times Cited: 868
The Many Faces of Tau
Meaghan Morris, Sumihiro Maeda, Keith Vossel, et al.
Neuron (2011) Vol. 70, Iss. 3, pp. 410-426
Open Access | Times Cited: 849
Network abnormalities and interneuron dysfunction in Alzheimer disease
Jorge J. Palop, Lennart Mucke
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 12, pp. 777-792
Open Access | Times Cited: 819
Roles of tau protein in health and disease
Tong Guo, Wendy Noble, Diane P. Hanger
Acta Neuropathologica (2017) Vol. 133, Iss. 5, pp. 665-704
Open Access | Times Cited: 815
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Antonio Paoli, Alessandro Rubini, Jeff S. Volek, et al.
European Journal of Clinical Nutrition (2013) Vol. 67, Iss. 8, pp. 789-796
Open Access | Times Cited: 784
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman, Joachim Herz, Guojun Bu
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 3, pp. a006312-a006312
Open Access | Times Cited: 737
Tau and neurodegenerative disease: the story so far
Khalid Iqbal, Fei Liu, Cheng‐Xin Gong
Nature Reviews Neurology (2015) Vol. 12, Iss. 1, pp. 15-27
Closed Access | Times Cited: 696
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Erik S. Musiek, David M. Holtzman
Nature Neuroscience (2015) Vol. 18, Iss. 6, pp. 800-806
Open Access | Times Cited: 645
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model
Pascal E. Sanchez, Lei Zhu, Laure Verret, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 42
Open Access | Times Cited: 596
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova, Sara Sanz‐Blasco, Xiaofei Zhang, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 27
Open Access | Times Cited: 529
Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
Ji Won Um, A Kaufman, Mikhail A. Kostylev, et al.
Neuron (2013) Vol. 79, Iss. 5, pp. 887-902
Open Access | Times Cited: 524
Tau and tauopathies
Thomas Arendt, Jens Stieler, Max Holzer
Brain Research Bulletin (2016) Vol. 126, pp. 238-292
Closed Access | Times Cited: 517
Epileptic activity in Alzheimer's disease: causes and clinical relevance
Keith Vossel, Maria Carmela Tartaglia, Haakon B. Nygaard, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 4, pp. 311-322
Open Access | Times Cited: 489
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
Ravi Rajmohan, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2016) Vol. 57, Iss. 4, pp. 975-999
Open Access | Times Cited: 481
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Shichun Tu, Shu‐ichi Okamoto, Stuart A. Lipton, et al.
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1, pp. 48-48
Open Access | Times Cited: 474
Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β
Elsa Suberbielle, Pascal E. Sanchez, Alexxai V. Kravitz, et al.
Nature Neuroscience (2013) Vol. 16, Iss. 5, pp. 613-621
Open Access | Times Cited: 452
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
Keith Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, et al.
Annals of Neurology (2016) Vol. 80, Iss. 6, pp. 858-870
Open Access | Times Cited: 447
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
Meaghan Morris, Giselle M. Knudsen, Sumihiro Maeda, et al.
Nature Neuroscience (2015) Vol. 18, Iss. 8, pp. 1183-1189
Open Access | Times Cited: 423
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
Sarah L. DeVos, Rebecca L. Miller, Kathleen M. Schoch, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 374
Open Access | Times Cited: 420
Page 1 - Next Page

Scroll to top